CTLA4 and neoplasm: Previous studies have shown that the interaction between tumor cells and CAR T cells may trigger the expression of immunosuppressive factors (such as cytotoxic T-lymphocyte-associated antigen 4 [CTLA-4] and programmed cell death protein 1 [PD-1]) resulting in T-cell exhaustion or dysfunction.